| Gene name: | WT1 |
| Aging type: | Prevent |
| Aging characteristic: |
| Tissue type: | -- |
| Cell name: | NCI-H522,NCI-H1437,NCI-H1568,NCI-H1650,NCI-H1975,NCI-H2126,NCI-H23,NCI-H358,NCI-H441,NCI-H460,NCI-H727,NCI-H1299,NCI-H2009,NCI-A549 |
| Experiment: | MTT assay//SA-β-gal activity assay |
| Description: | A significant decrease in the cell viability of cell lines harboring KRAS mutations was observed in response to WT1 loss.Mutant KRAS NSCLC cell lines adopted a senescence-like appearance in response to WT1 knockdown, and this was confirmed by staining with SA-βgal. |
| Regulatory pathway: | KRAS |
| R-AG-Pathway: | -- |
| Official symbol(s): | KRAS |
| Pathway experiment: | SA-β-gal activity assay//Tumor formation assay |
| Pathway description: | KrasG12D/+;Wt1Δ/Δ MEFs demonstrated a flattened morphology and stained positive for senescence-associated β-gal (SA-βgal). Wt1 suppression significantly decreased the size of tumors when compared with controls and to a level similar to that caused by suppression of Kras. |
Annotation:
Loading,please wait...